251 related articles for article (PubMed ID: 22293932)
21. Induced pluripotent stem cells expressing elevated levels of sox-2, oct-4, and klf-4 are severely reduced in their differentiation from mesodermal to hematopoietic progenitor cells.
Seiler K; Soroush Noghabi M; Karjalainen K; Hummel M; Melchers F; Tsuneto M
Stem Cells Dev; 2011 Jul; 20(7):1131-42. PubMed ID: 21348597
[TBL] [Abstract][Full Text] [Related]
22. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming.
Wei Z; Yang Y; Zhang P; Andrianakos R; Hasegawa K; Lyu J; Chen X; Bai G; Liu C; Pera M; Lu W
Stem Cells; 2009 Dec; 27(12):2969-78. PubMed ID: 19816951
[TBL] [Abstract][Full Text] [Related]
23. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.
Kim JB; Zaehres H; Wu G; Gentile L; Ko K; Sebastiano V; Araúzo-Bravo MJ; Ruau D; Han DW; Zenke M; Schöler HR
Nature; 2008 Jul; 454(7204):646-50. PubMed ID: 18594515
[TBL] [Abstract][Full Text] [Related]
24. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes.
Aasen T; Raya A; Barrero MJ; Garreta E; Consiglio A; Gonzalez F; Vassena R; Bilić J; Pekarik V; Tiscornia G; Edel M; Boué S; Izpisúa Belmonte JC
Nat Biotechnol; 2008 Nov; 26(11):1276-84. PubMed ID: 18931654
[TBL] [Abstract][Full Text] [Related]
25. Endogenous KLF4 expression in human fetal endothelial cells allows for reprogramming to pluripotency with just OCT3/4 and SOX2--brief report.
Ho PJ; Yen ML; Lin JD; Chen LS; Hu HI; Yeh CK; Peng CY; Lin CY; Yet SF; Yen BL
Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1905-7. PubMed ID: 20689077
[TBL] [Abstract][Full Text] [Related]
26. Induced pluripotency with endogenous and inducible genes.
Duinsbergen D; Eriksson M; 't Hoen PA; Frisén J; Mikkers H
Exp Cell Res; 2008 Oct; 314(17):3255-63. PubMed ID: 18656469
[TBL] [Abstract][Full Text] [Related]
27. Increased reprogramming capacity of mouse liver progenitor cells, compared with differentiated liver cells, requires the BAF complex.
Kleger A; Mahaddalkar PU; Katz SF; Lechel A; Joo JY; Loya K; Lin Q; Hartmann D; Liebau S; Kraus JM; Cantz T; Kestler HA; Zaehres H; Schöler H; Rudolph KL
Gastroenterology; 2012 Apr; 142(4):907-17. PubMed ID: 22245845
[TBL] [Abstract][Full Text] [Related]
28. Dicer 1, ribonuclease type III modulates a reprogramming effect in colorectal cancer cells.
Dewi DL; Ishii H; Haraguchi N; Nishikawa S; Kano Y; Fukusumi T; Ozaki M; Saito T; Sakai D; Satoh T; Doki Y; Mori M
Int J Mol Med; 2012 Jun; 29(6):1060-4. PubMed ID: 22446887
[TBL] [Abstract][Full Text] [Related]
29. Landmark approach to generating human stem cells.
Daubman S
Circ Res; 2011 Jan; 108(2):161-3. PubMed ID: 21252149
[No Abstract] [Full Text] [Related]
30. Simple and efficient method for generation of induced pluripotent stem cells using piggyBac transposition of doxycycline-inducible factors and an EOS reporter system.
Tsukiyama T; Asano R; Kawaguchi T; Kim N; Yamada M; Minami N; Ohinata Y; Imai H
Genes Cells; 2011 Jul; 16(7):815-25. PubMed ID: 21658168
[TBL] [Abstract][Full Text] [Related]
31. Oct4-enhanced green fluorescent protein transgenic pigs: a new large animal model for reprogramming studies.
Nowak-Imialek M; Kues WA; Petersen B; Lucas-Hahn A; Herrmann D; Haridoss S; Oropeza M; Lemme E; Schöler HR; Carnwath JW; Niemann H
Stem Cells Dev; 2011 Sep; 20(9):1563-75. PubMed ID: 21126163
[TBL] [Abstract][Full Text] [Related]
32. Comparison of reprogramming efficiency between transduction of reprogramming factors, cell-cell fusion, and cytoplast fusion.
Hasegawa K; Zhang P; Wei Z; Pomeroy JE; Lu W; Pera MF
Stem Cells; 2010 Aug; 28(8):1338-48. PubMed ID: 20572011
[TBL] [Abstract][Full Text] [Related]
33. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells.
Meissner A; Wernig M; Jaenisch R
Nat Biotechnol; 2007 Oct; 25(10):1177-81. PubMed ID: 17724450
[TBL] [Abstract][Full Text] [Related]
34. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
[TBL] [Abstract][Full Text] [Related]
35. Generation of pig iPS cells: a model for cell therapy.
Montserrat N; Bahima EG; Batlle L; Häfner S; Rodrigues AM; González F; Izpisúa Belmonte JC
J Cardiovasc Transl Res; 2011 Apr; 4(2):121-30. PubMed ID: 21088946
[TBL] [Abstract][Full Text] [Related]
36. Reprogramming of mouse renal tubular epithelial cells to induced pluripotent stem cells.
Wang WW; Wang W; Jiang Y; Han GF; Lu S; Li G; Zhang J
Cytotherapy; 2013 May; 15(5):578-85. PubMed ID: 23415920
[TBL] [Abstract][Full Text] [Related]
37. Using small molecules to improve generation of induced pluripotent stem cells from somatic cells.
Desponts C; Ding S
Methods Mol Biol; 2010; 636():207-18. PubMed ID: 20336525
[TBL] [Abstract][Full Text] [Related]
38. Mouse induced pluripotent stem cells.
Geoghegan E; Byrnes L
Int J Dev Biol; 2008; 52(8):1015-22. PubMed ID: 18956334
[TBL] [Abstract][Full Text] [Related]
39. Overexpression Nanog activates pluripotent genes in porcine fetal fibroblasts and nuclear transfer embryos.
Zhang L; Luo YB; Bou G; Kong QR; Huan YJ; Zhu J; Wang JY; Li H; Wang F; Shi YQ; Wei YC; Liu ZH
Anat Rec (Hoboken); 2011 Nov; 294(11):1809-17. PubMed ID: 21972213
[TBL] [Abstract][Full Text] [Related]
40. The magic of four: induction of pluripotent stem cells from somatic cells by Oct4, Sox2, Myc and Klf4.
Qi H; Pei D
Cell Res; 2007 Jul; 17(7):578-80. PubMed ID: 17632550
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
